Abstract Library

#2792 Post-Transplant Recurrence of Neuroendocrine Tumors

Introduction: Recurrence after liver transplantation (LT) for metastases from NET is observed in 30-50% of cases at 5 years after LT but management is individualized

Conference: 17th Annual ENETSConcerence (2020)

Presenting Author:

Authors: Monteleone M, Sposito C, Rossi R, Pusceddu S, Coppa J,

Keywords: Liver transplantation, Recurrence, Liver metastases,

#1927 Conditional Survival (CS) Analysis of Liver Resection (LR) for Gastro-Entero-Pancreatic Neuroendocrine Tumor (GEP-NET).

Introduction: LR with curative intent in metastatic GEP-NET is rarely feasible associated with improved survival and symptoms control. CS is the probability that pts will survive an additional number of yrs given that they have already survived at a certain interval

Conference: 14th Annual ENETSConcerence (2017)

Presenting Author: coppa J

Authors: Coppa J, Bongini M, Scotti M, Flores M, Bianchi Z,

Keywords: Survival, Liver resection,GEP-NET,

#1753 Ki67 Is Able to Predict Pancreatic NENs Prognosis Irrespective of Their Size

Introduction: In pancreatic neuroendocrine neoplasms (pNENs), size <20mm and Ki67≤2% suggest indolent behavior. None of these factors alone predicts prognosis. No other predictive factors have been suggested.

Conference: 14th Annual ENETSConcerence (2017)

Presenting Author: Milione M

Authors: Milione M, Maisonneuve P, Pellegrinelli A, Centonze G, Coppa J,

Keywords: Ki67, PFS, pancreatic, NEN,

#1451 Pancreatic NENs <2 cm Could Represent a New Entity Worth of Further Investigation

Introduction: Surgical approach to the treatment of well-differentiated pancreatic neuroendocrine neoplasms (pNENs) is based on tumor size and Ki67. Surgical removal is not recommended for tumors <2cm, due to their indolent nature. Ki67≤2% and size <2cm are considered indicative of benign tumors. However, size and Ki67 may not correctly predict the prognosis of patients with pNENs <2cm.

Conference: 13th Annual ENETSConcerence (2016)

Presenting Author: Milione M

Authors: Milione M, Maisonneuve P, Alessio P, Centonze G, Coppa J,

Keywords: NEN, <2cm, prognosis,

#964 Ewing Sarcoma a Dangerous Pitfall for Poorly Differentiated Neuroendocrine Carcinoma (PDEC) in Ileum

Introduction: Ewing sarcoma (ES) primary to the ileum (IES) has rarely been documented, and shows close similarities in histology and clinical presentation with PDEC.EWSR1-FEV translocation is exceedingly rare in ES, as FEV expression is restricted to prostate, brain, and serotonin neuroendocrine cells (NE) and related tumors.

Conference: 11th Annual ENETSConcerence (2014)

Presenting Author: Milione M

Authors: Milione M, Gasparini P, Coppa J, Pusceddu S, Pellegrinelli A,

Keywords: ileum, neuroendocrine, Ewing Sarcoma, EWSR1,